Delivery Order SPE2DB20D3303-SPE2DB24FA0DS

Award Date 6/20/24
Potential Completion Date 6/21/24
Potential Value $6.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $5,162.96 firm fixed price delivery order is for the supply of the pharmaceutical product Cosentyx, a medication used to treat certain autoimmune conditions. The contract has a completion date of June 4, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $3,043.90 Firm Fixed Price Delivery Order is for the supply of the drug product Cosentyx (300 mg dose, 2 pens per milliliter) to the DLA. The contract has a period of performance through June 12, 2024. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The $3,043.90 firm-fixed-price delivery order is for the supply of Cosentyx 300 mg dose-2 syringes, a prescription drug used to treat various chronic conditions. The contract has a period of performance through July 10, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies in the world, has been awarded an Indefinite Delivery...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the supply of the pharmaceutical product Cosentyx (300mg dose) to the U.S. government. The single-award Indefinite Delivery Contract (IDC) is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This contract serves as the primary vehicle for Amerisourcebergen to provide a wide range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,702.06, is a Firm Fixed Price Delivery Order for the supply of the medication Cosentyx. The contract has an ultimate completion date of February 18, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Cosentyx, a specialty medication. The $3,149.12 firm-fixed-price delivery order has a completion date of December 3, 2024 and is not associated with any set-aside requirements. Amerisourcebergen holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the provision of Cosentyx, a prescription medication. The delivery order has a firm fixed price of $12,877.57 and an ultimate completion date of May 24, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of pharmaceutical products, specifically the medication Cosentyx, to the Department of Defense (DoD) and its Medical Supply Chain. The contract, valued at $2,008.73, is a Firm Fixed Price Delivery Order with a completion date of June 28, 2024. Amerisourcebergen, as a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Cosentyx, a specialty medication. The $11,507.47 firm fixed price contract has an ultimate completion date of January 13, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $26,529.39, was issued to Amerisourcebergen Drug Corp's Corporate Office division by the Medical Supply Chain, a component of the Defense Department's Defense Logistics Agency (DLA). The contract is for the delivery of Cosentyx, a prescription medication, to support the medical needs of the U.S. government. This is a firm fixed-price delivery order contract with a period of performance through May 2024. Amerisourcebergen Drug Corp is a major...
  • SPE2DB20D3303
    Indefinite Delivery Contract
  • SPE2DB20D3303-SPE2DB24FA0DS
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $6,176.72 firm fixed-price delivery order is for the pharmaceutical product Cosentyx, a drug used to treat certain chronic conditions. The contract has an ultimate completion date of June 21, 2024.

Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024. This contract award was not set aside for any specific business designation.

Generated 9/19/24, 9:42 AM